What a reviewer looks for
- A good-faith exam that precedes each treatment, signed by a qualified prescriber.
- An order or standing order that covers the treatment that was given.
- Complete consent, product lot numbers, dosing and injection sites.
- Complications and adverse events recorded, with follow-up.
- Delegated care performed by a licensed team member who was authorized to do it.
Cadence and documentation
The agreement between practice and director normally sets the schedule, such as monthly sampling of charts, and the sample size. The important part is the record: the date, the charts reviewed, what was found, and what was corrected. A review that leaves no trace cannot be shown to anyone later.
Charts signed in a batch at the end of the week, without evidence the director actually evaluated the patient beforehand, can create more exposure than it removes. Review should confirm the sequence of events, not manufacture it.
What a useful review looks like
Chart review is only meaningful if it is done and documented: which charts were reviewed, by whom, when, and what was found. Frequency and scope should be set in the written agreement and then actually followed.
Common mistakes
- Signing off on charts in batches without reading them.
- Having no record that a review took place.
- Leaving the frequency vague in the agreement.
Frequently asked
How often should charts be reviewed?
There is no single number that fits every practice. The frequency and sample size should be written into the medical director agreement and match your volume and risk.
Who can perform chart review?
The medical director, or another qualified prescriber designated in the agreement. Their review is only meaningful if they are actively involved in the practice's clinical framework.
Educational information only, not legal or clinical advice. Rules and Board positions change, so confirm current requirements with the relevant Arizona licensing board and an Arizona healthcare attorney.